Free Trial

Teleflex (NYSE:TFX) Sets New 1-Year Low - Here's Why

Teleflex logo with Medical background

Teleflex Incorporated (NYSE:TFX - Get Free Report) reached a new 52-week low on Monday . The company traded as low as $116.60 and last traded at $117.80, with a volume of 1263650 shares trading hands. The stock had previously closed at $117.72.

Analyst Upgrades and Downgrades

A number of research analysts have commented on TFX shares. Morgan Stanley cut their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Wells Fargo & Company decreased their price target on Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, May 2nd. Mizuho set a $155.00 price objective on Teleflex in a research note on Wednesday, April 16th. Royal Bank Of Canada reduced their target price on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. Finally, Citizens Jmp lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. One analyst has rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $164.63.

Check Out Our Latest Stock Report on TFX

Teleflex Stock Performance

The stock's 50 day simple moving average is $124.81 and its two-hundred day simple moving average is $148.76. The company has a market capitalization of $5.28 billion, a P/E ratio of 37.68, a P/E/G ratio of 1.87 and a beta of 1.10. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.28 and a quick ratio of 1.32.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. Teleflex's revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.21 EPS. As a group, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Tuesday, May 20th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.14%. The ex-dividend date was Tuesday, May 20th. Teleflex's dividend payout ratio is 42.90%.

Institutional Trading of Teleflex

Several institutional investors and hedge funds have recently added to or reduced their stakes in TFX. Sanctuary Advisors LLC grew its position in shares of Teleflex by 28.2% during the 4th quarter. Sanctuary Advisors LLC now owns 6,251 shares of the medical technology company's stock worth $1,143,000 after buying an additional 1,374 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Teleflex by 43.0% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 11,644 shares of the medical technology company's stock worth $2,072,000 after purchasing an additional 3,500 shares during the period. IFP Advisors Inc lifted its stake in Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after buying an additional 217 shares in the last quarter. Bryn Mawr Capital Management LLC bought a new stake in Teleflex in the 4th quarter valued at $213,000. Finally, Proficio Capital Partners LLC acquired a new position in shares of Teleflex during the fourth quarter worth about $3,297,000. 95.62% of the stock is owned by institutional investors.

About Teleflex

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Recommended Stories

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential
Time to Cash Out? 5 Stocks to Drop Before Earnings

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines